Literature DB >> 17428153

Whole-body physiologically based pharmacokinetic models.

Ivan Nestorov1.   

Abstract

This review summarizes the most recent developments in and applications of physiologically based pharmacokinetic (PBPK) modeling methodology originating from both the pharmaceutical and environmental toxicology areas. It focuses on works published in the last 5 years, although older seminal papers have also been referenced. After a brief introduction to the field and several essential definitions, the main body of the text is structured to follow the major steps of a typical PBPK modeling exercise. Various applications of the methodology are briefly described. The major future trends and perspectives are outlined. The main conclusion from the review of the available literature is that PBPK modeling, despite its obvious potential and recent incremental developments, has not taken the place it deserves, especially in pharmaceutical and drug development sciences.

Mesh:

Substances:

Year:  2007        PMID: 17428153     DOI: 10.1517/17425255.3.2.235

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  47 in total

1.  BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Authors:  John F Graf; Bernhard J Scholz; Maria I Zavodszky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

5.  Physiologically based pharmacokinetic modeling of drug disposition in rat and human: a fuzzy arithmetic approach.

Authors:  Kok-Yong Seng; Ivan Nestorov; Paolo Vicini
Journal:  Pharm Res       Date:  2008-03-25       Impact factor: 4.200

6.  Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory.

Authors:  Armin Sepp; Alienor Berges; Andrew Sanderson; Guy Meno-Tetang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-01-11       Impact factor: 2.745

Review 7.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

8.  A physiologically-based recirculatory meta-model for nasal fentanyl in man.

Authors:  Richard N Upton; David J R Foster; Lona L Christrup; Ola Dale; Kristin Moksnes; Lars Popper
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-19       Impact factor: 2.745

9.  A generalized physiologically-based toxicokinetic modeling system for chemical mixtures containing metals.

Authors:  Alan F Sasso; Sastry S Isukapalli; Panos G Georgopoulos
Journal:  Theor Biol Med Model       Date:  2010-06-02       Impact factor: 2.432

10.  An imaging-driven model for liposomal stability and circulation.

Authors:  Shengping Qin; Jai Woong Seo; Hua Zhang; Jinyi Qi; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.